e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Cystic fibrosis lung disease: what do we measure? What do we know?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measuring patient compliance in inhalation studies by smart card technology
A. Fischer, B. Müllinger, T. Arendt, T. Bernhardt, K. Hannah, G. Scheuch (Gemünden, Leverkusen, Gauting, Germany; Research Triangle Park, United States Of America)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Session:
Cystic fibrosis lung disease: what do we measure? What do we know?
Session type:
Electronic Poster Discussion
Number:
356
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Fischer, B. Müllinger, T. Arendt, T. Bernhardt, K. Hannah, G. Scheuch (Gemünden, Leverkusen, Gauting, Germany; Research Triangle Park, United States Of America). Measuring patient compliance in inhalation studies by smart card technology. Eur Respir J 2007; 30: Suppl. 51, 356
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Evaluation of the technique of use of inhaler devices by patients at home through a video mobile application: A pilot study
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
A qualitative study of user perspectives on electronic monitoring devices for adherence in asthma
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Use of a telemedicine application to examine patient logging system data from a 3-month use of an adaptive aerosol delivery system by patients with COPD
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008
How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Clinical feasibility study utilizing multi-sensor devices with the goal of developing remote monitoring digital health solutions for patients with asthma or COPD
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Internet-based home asthma telemonitoring - can patients handle the technology?
Source: Annual Congress 2007 - Primary care: information technology: new ways of monitoring in primary care
Year: 2007
Validation study of the quality of home spirometry performed by Air Next spirometer in combination with mobile coaching system: preliminary results
Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases
Year: 2020
Compliance of asthmatic children to lockdown measures for the COVID-19 pandemic: Objective assessment using wearable sensors.
Source: Virtual Congress 2021 – Paediatric asthma and bronchopulmonary dysplasia
Year: 2021
Can the use of adaptive aerosol delivery technology increase the quality of life for patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 611s
Year: 2007
A new tool for monitoring patient adherence with aerosol therapy using an eflow nebulizer system
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
In vitro performance of the prodose AAD® handheld - a new portable aerosol delivery system
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004
Benchmarking a portable spirometer for use in epidemiological research
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010
Exploring the potential benefits of digital health technology for the management of COPD: a qualitative study of patient perceptions
Source: ERJ Open Res, 5 (2) 00239-2018; 10.1183/23120541.00239-2018
Year: 2019
Oxygen wristbands, a visual aid to aid patient safety
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018
Which device for which patient? Criteria for selecting inhaler devices
Source: Annual Congress 2012 - Asthma management
Year: 2012
Standardising inhaler technique videos in a clinician and patient app
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
A meta-analysis of the effectiveness of smart phone applications to aid smoking cessation
Source: International Congress 2019 – Old and new approaches to support tobacco cessation
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept